Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz(Memorial Sloan Kettering Cancer Center), Jonathan J. Havel(Memorial Sloan Kettering Cancer Center), Vladimir Makarov(Memorial Sloan Kettering Cancer Center), Alexis Desrichard(Memorial Sloan Kettering Cancer Center), Walter J. Urba(Providence Portland Medical Center), Jennifer S. Sims(Memorial Sloan Kettering Cancer Center), F. Stephen Hodi(Dana-Farber Cancer Institute), Salvador Martín‐Algarra(Navarre Institute of Health Research), Rajarsi Mandal(Memorial Sloan Kettering Cancer Center), William H. Sharfman(Johns Hopkins University), Shailender Bhatia(University of Washington), Wen-Jen Hwu(The University of Texas MD Anderson Cancer Center), Thomas F. Gajewski(University of Chicago), Craig L. Slingluff(University of Virginia), Diego Chowell(Memorial Sloan Kettering Cancer Center), Sviatoslav M. Kendall(Memorial Sloan Kettering Cancer Center), Han Chang(Bristol-Myers Squibb (United States)), Rachna Shah(Memorial Sloan Kettering Cancer Center), Fengshen Kuo(Memorial Sloan Kettering Cancer Center), Luc G.T. Morris(Memorial Sloan Kettering Cancer Center), John-William Sidhom(Johns Hopkins University), Jonathan P. Schneck(Johns Hopkins University), Christine E. Horak(Bristol-Myers Squibb (United States)), Nils Weinhold(Memorial Sloan Kettering Cancer Center), Timothy A. Chan(Memorial Sloan Kettering Cancer Center)
Cited by 2,545Open Access